We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
55 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CLADRITAB cladribine 10mg tablet blister pack.
-
Prescription medicine registrationActive ingredients: Somatropin.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TEPMETKO tepotinib 225 mg (as hydrochloride monohydrate) tablet blister pack.
-
Designation or determinationOrphan drug
-
Australian public assessment report (AusPar)Tepmetko (tepotinib) for treatment of non-small cell lung cancer with MET exon 14 skipping alterations.
-
Prescription medicine decision summaryTGA decision: Tepmetko (tepotinib) is approved to treat locally advanced or metastatic non-small cell lung cancer (NSCLC).
-
Prescription medicine registrationActive ingredients: tepotinib hydrochloride monohydrate.
-
Prescription medicine registrationActive ingredients: tepotinib hydrochloride monohydrate.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Merck Healthcare Pty Ltd - Needle, injector, medication/vaccine.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Merck Healthcare Pty Ltd - Needle, injector, medication/vaccine.